12:00 AM
Feb 28, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

CyPath: Completed Phase II enrollment

Biomoda completed enrollment in a single-blind, U.S Phase II trial of CyPath. In October, the company amended the trial to enroll additional patients after determining that it did not...

Read the full 123 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >